These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23849306)

  • 21. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.
    Zoccali C; Mallamaci F; Maas R; Benedetto FA; Tripepi G; Malatino LS; Cataliotti A; Bellanuova I; Böger R;
    Kidney Int; 2002 Jul; 62(1):339-45. PubMed ID: 12081596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
    Kendrick J; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Chonchol M;
    J Am Soc Nephrol; 2011 Oct; 22(10):1913-22. PubMed ID: 21903574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
    Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
    Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction.
    Quiñones MA; Greenberg BH; Kopelen HA; Koilpillai C; Limacher MC; Shindler DM; Shelton BJ; Weiner DH
    J Am Coll Cardiol; 2000 Apr; 35(5):1237-44. PubMed ID: 10758966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.
    Masson S; Agabiti N; Vago T; Miceli M; Mayer F; Letizia T; Wienhues-Thelen U; Mureddu GF; Davoli M; Boccanelli A; Latini R;
    J Intern Med; 2015 Mar; 277(3):318-330. PubMed ID: 24620922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast Growth Factor 23 and Blood Pressure in Older Adults: The Health, Aging, and Body Composition Study.
    Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak MG; Newman AB; Hoofnagle AN; Fried LF; Sarnak M; Gutiérrez OM
    Hypertension; 2020 Jul; 76(1):236-243. PubMed ID: 32418499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
    Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
    Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial mass and volume measurement of hypertrophic left ventricles by MRI--study in dialysis patients examined before and after dialysis.
    Hunold P; Vogt FM; Heemann UW; Zimmermann U; Barkhausen J
    J Cardiovasc Magn Reson; 2003; 5(4):553-61. PubMed ID: 14664133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure and cardiovascular mortality in dialysis patients with left ventricular systolic dysfunction.
    Losito A; Del Vecchio L; Del Rosso G; Malandra R;
    Am J Hypertens; 2014 Mar; 27(3):401-8. PubMed ID: 24108864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.
    Assa S; Hummel YM; Voors AA; Kuipers J; Westerhuis R; de Jong PE; Franssen CF
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1615-23. PubMed ID: 22822014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of quantitative analysis of left ventricular systolic function in patients on maintenance hemodialysis based on myocardial work technique.
    Liu C; Feng YP; Yan ZN; Fan L; Rui YF; Cui L
    BMC Cardiovasc Disord; 2021 Feb; 21(1):76. PubMed ID: 33549050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular twist and ventricular-arterial coupling in hypertensive patients.
    Shin HW; Kim H; Lee JE; Kim IC; Yoon HJ; Park HS; Cho YK; Nam CW; Hur SH; Kim YN; Kim KB
    Echocardiography; 2014 Nov; 31(10):1274-82. PubMed ID: 24640942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of left ventricular systolic dysfunction on left atrial appendage and left atrial functions in patients with chronic nonvalvular atrial fibrillation.
    Cemri M; Timurkaynak T; Ozdemir M; Boyaci B; Yalcin R; Cengel A; Dörtlemez O; Dörtlemez H
    Acta Cardiol; 2002 Apr; 57(2):101-5. PubMed ID: 12003255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with
    Assa S; Kuipers J; Ettema E; Gaillard CAJM; Krijnen WP; Hummel YM; Voors AA; van Melle JP; Westerhuis R; Willemsen A; Slart RHJA; Franssen CFM
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F445-F452. PubMed ID: 29117996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.
    Liu JE; Robbins DC; Palmieri V; Bella JN; Roman MJ; Fabsitz R; Howard BV; Welty TK; Lee ET; Devereux RB
    J Am Coll Cardiol; 2003 Jun; 41(11):2022-8. PubMed ID: 12798576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry.
    Wang H; Liu J; Yao XD; Li J; Yang Y; Cao TS; Yang B
    Nephrol Dial Transplant; 2012 Dec; 27(12):4422-9. PubMed ID: 22561582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in components of left ventricular mechanics under selective beta-1 blockade: insight from traditional and new technologies in echocardiography.
    Palmieri V; Russo C; Palmieri EA; Pezzullo S; Celentano A
    Eur J Echocardiogr; 2009 Aug; 10(6):745-52. PubMed ID: 19465587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deleterious effect of right ventricular apical pacing on left ventricular diastolic function and the impact of pre-existing diastolic disease.
    Fang F; Zhang Q; Chan JY; Xie JM; Fung JW; Yip GW; Lam YY; Chan A; Yu CM
    Eur Heart J; 2011 Aug; 32(15):1891-9. PubMed ID: 21531741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients.
    Kirkpantur A; Balci M; Gurbuz OA; Afsar B; Canbakan B; Akdemir R; Ayli MD
    Nephrol Dial Transplant; 2011 Apr; 26(4):1346-54. PubMed ID: 20813767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.